Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by premium54on Jan 19, 2017 7:48am
135 Views
Post# 25726738

RE:RE:RE:RE:RE:IIROC Trading Halt - KALY

RE:RE:RE:RE:RE:IIROC Trading Halt - KALYFolks, dont underestimate what is going on here.  The drug we are talking about is effective in 
situations that involve rejection, namely the body attacking itself.  This isnt just about
transplants.

The number of diseases that involve the body rejecting itself include arthritis,osteoporosis
chrons disease and many many more.

This is not small stuff, if this drug works like it has so far this company will be huge.

JMHO
Bullboard Posts